FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029595472> ?p ?o ?g. }

• W2029595472 endingPage "375" @default.
• W2029595472 startingPage "365" @default.
• W2029595472 abstract "Background: A single intramuscular treatment with botulinum toxin A (BoNT-A) into the facial muscles underlying glabellar rhytids has been shown to effectively attenuate or totally erase these lines for at least 3 months. Objective: We sought to evaluate the optimal time for a second injection of BoNT-A (Dysport, Ipsen). Methods: One hundred patients with moderate to severe glabellar rhytids at rest were randomized to a first, double-blind injection of 50 U of BoNT-A (n = 50) divided into 5 intramuscular sites, or placebo (n = 50). At monthly intervals between Month 3 and Month 6, the patient and the investigator consensually decided to repeat the injection with open-label BoNT-A in both groups. The main outcome was the time between the first and second injections. Responder ratings (mild or no glabellar lines) after the first and second injections, patient satisfaction, and safety were also assessed. Results: At Months 3 and 4 after the first injection, the cumulative percentage of patients having a second injection was lower in the BoNT-A group compared to the placebo group, with a significant difference at Month 4. Following the first double-blind injection, responder rates were significantly higher in BoNT-A group (up to 75%) compared to placebo up to Month 4, and a large majority of patients were significantly satisfied with the BoNT-A treatment at Month 4 (75% satisfied and completely satisfied versus 9.1% with placebo) and Month 5 (86.7% versus 0%, respectively). Headache was the most frequent adverse event in the BoNT-A group (10% versus 6% in the placebo group). No blepharoptosis was reported. Conclusions: The effectiveness of 50 U of BoNT-A was confirmed for the treatment of glabellar lines. A second injection was sought within 3 to 4 months by most patients and investigators. Both injections were safe." @default.
• W2029595472 created "2016-06-24" @default.
• W2029595472 creator A5001942149 @default.
• W2029595472 creator A5027332510 @default.
• W2029595472 creator A5057032892 @default.
• W2029595472 creator A5058665723 @default.
• W2029595472 creator A5067489306 @default.
• W2029595472 creator A5076323245 @default.
• W2029595472 creator A5081848993 @default.
• W2029595472 creator A5055329050 @default.
• W2029595472 date "2005-07-01" @default.
• W2029595472 modified "2023-10-16" @default.
• W2029595472 title "Botulinum toxin A in the treatment of glabellar lines: Scheduling the next injection" @default.
• W2029595472 cites W1969772266 @default.
• W2029595472 cites W1976073427 @default.
• W2029595472 cites W1977815227 @default.
• W2029595472 cites W1978910356 @default.
• W2029595472 cites W1999410523 @default.
• W2029595472 cites W2019469593 @default.
• W2029595472 cites W2020251506 @default.
• W2029595472 cites W2030342052 @default.
• W2029595472 cites W2033132384 @default.
• W2029595472 cites W2072504962 @default.
• W2029595472 cites W2076715034 @default.
• W2029595472 cites W2088367424 @default.
• W2029595472 cites W2093071349 @default.
• W2029595472 cites W2129235087 @default.
• W2029595472 cites W2304759253 @default.
• W2029595472 cites W2397538618 @default.
• W2029595472 cites W2416336456 @default.
• W2029595472 cites W2443532450 @default.
• W2029595472 cites W43666815 @default.
• W2029595472 cites W2097878172 @default.
• W2029595472 doi "https://doi.org/10.1016/j.asj.2005.05.004" @default.
• W2029595472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19338833" @default.
• W2029595472 hasPublicationYear "2005" @default.
• W2029595472 type Work @default.
• W2029595472 sameAs 2029595472 @default.
• W2029595472 citedByCount "50" @default.
• W2029595472 countsByYear W20295954722012 @default.
• W2029595472 countsByYear W20295954722013 @default.
• W2029595472 countsByYear W20295954722014 @default.
• W2029595472 countsByYear W20295954722015 @default.
• W2029595472 countsByYear W20295954722016 @default.
• W2029595472 countsByYear W20295954722017 @default.
• W2029595472 countsByYear W20295954722018 @default.
• W2029595472 countsByYear W20295954722019 @default.
• W2029595472 countsByYear W20295954722020 @default.
• W2029595472 countsByYear W20295954722021 @default.
• W2029595472 countsByYear W20295954722022 @default.
• W2029595472 crossrefType "journal-article" @default.
• W2029595472 hasAuthorship W2029595472A5001942149 @default.
• W2029595472 hasAuthorship W2029595472A5027332510 @default.
• W2029595472 hasAuthorship W2029595472A5055329050 @default.
• W2029595472 hasAuthorship W2029595472A5057032892 @default.
• W2029595472 hasAuthorship W2029595472A5058665723 @default.
• W2029595472 hasAuthorship W2029595472A5067489306 @default.
• W2029595472 hasAuthorship W2029595472A5076323245 @default.
• W2029595472 hasAuthorship W2029595472A5081848993 @default.
• W2029595472 hasBestOaLocation W20295954721 @default.
• W2029595472 hasConcept C126322002 @default.
• W2029595472 hasConcept C141071460 @default.
• W2029595472 hasConcept C142724271 @default.
• W2029595472 hasConcept C197934379 @default.
• W2029595472 hasConcept C204787440 @default.
• W2029595472 hasConcept C27081682 @default.
• W2029595472 hasConcept C2776291583 @default.
• W2029595472 hasConcept C2777478456 @default.
• W2029595472 hasConcept C2991744798 @default.
• W2029595472 hasConcept C3018125106 @default.
• W2029595472 hasConcept C42219234 @default.
• W2029595472 hasConcept C71924100 @default.
• W2029595472 hasConceptScore W2029595472C126322002 @default.
• W2029595472 hasConceptScore W2029595472C141071460 @default.
• W2029595472 hasConceptScore W2029595472C142724271 @default.
• W2029595472 hasConceptScore W2029595472C197934379 @default.
• W2029595472 hasConceptScore W2029595472C204787440 @default.
• W2029595472 hasConceptScore W2029595472C27081682 @default.
• W2029595472 hasConceptScore W2029595472C2776291583 @default.
• W2029595472 hasConceptScore W2029595472C2777478456 @default.
• W2029595472 hasConceptScore W2029595472C2991744798 @default.
• W2029595472 hasConceptScore W2029595472C3018125106 @default.
• W2029595472 hasConceptScore W2029595472C42219234 @default.
• W2029595472 hasConceptScore W2029595472C71924100 @default.
• W2029595472 hasIssue "4" @default.
• W2029595472 hasLocation W20295954721 @default.
• W2029595472 hasLocation W20295954722 @default.
• W2029595472 hasOpenAccess W2029595472 @default.
• W2029595472 hasPrimaryLocation W20295954721 @default.
• W2029595472 hasRelatedWork W144574125 @default.
• W2029595472 hasRelatedWork W1487832333 @default.
• W2029595472 hasRelatedWork W1559935205 @default.
• W2029595472 hasRelatedWork W180006690 @default.
• W2029595472 hasRelatedWork W1971288169 @default.
• W2029595472 hasRelatedWork W2006995345 @default.
• W2029595472 hasRelatedWork W2037973739 @default.
• W2029595472 hasRelatedWork W2183525504 @default.
• W2029595472 hasRelatedWork W2212130288 @default.

• next